galactose has been researched along with Viremia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Mohsen, M; Anzurez, A; Colomb, F; Giron, LB; Kaplan, RC; Kossenkov, AV; Landay, AL; Lauc, G; Lynn, K; Montaner, LJ; Mounzer, K; Papasavvas, E; Trbojevic-Akmacic, I; Vadrevu, SK | 1 |
| Bianchi, L; Dällenbach, A; Reichen, J; Renner, EL; Schmid, M; Solioz, M | 1 |
2 other study(ies) available for galactose and Viremia
| Article | Year |
|---|---|
Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Galactose; HIV Infections; Humans; Immunoglobulin G; Male; Plasma; Viral Load; Viremia | 2018 |
[Does serum HCV-RNA-positive hepatitis C differ from serum HCV-RNA-negative hepatitis C?].
Topics: Adult; Aged; Biopsy, Needle; Breath Tests; Female; Galactose; Hepatitis C; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Prognosis; RNA, Viral; Viremia | 1995 |